Skip to main content Skip to main navigation menu Skip to site footer

Cost for traffic accident related injuries and its comparison it with the national standard: A case study in Iran

  • Somayeh Mahdiyan Mahdiyan ,
  • Kavos Asgari Asgari ,
  • Mohammad Ranjbar ,


Abstract

Introduction: Since the World Health Organization (WHO) has emphasized the importance of estimating the economic costs and traffic-related injuries the society as well as their roles in the analysis of cost efficiency; traffic-related accidents toll estimation has risen as one of the main concerns of the WHO.

Materials and methods: This analytical, descriptive study is an applied research conducted in 2015 in Isfahan province. Among the 35 educational health centers and hospitals in Isfahan, 19 hospitals were selected randomly according to the type of the centers. Information was gathered using traffic accidents system and imported into the Microsoft Excel software. In a country standard, the cost for each patient in traffic accident by NO. 400/11607, dated 9/7/2016 has announced from the Ministry of Health and Medical Education to the Isfahan University of Medical Sciences.

Results: The highest average spending per injured patient is in the Imam Musa Kazim hospital, and lowest average spending per patient can be seen in the hospital Behnia Tiran. (Please elaborate more information in this section)

Discussion and Conclusion: Imam Musa Kazem and Imam Hussein Children’s Teaching Hospital including: the high average of staying patients, type and cost of equipment in Al Zahra educational health treatment center, the consuming prostheses and the utilization of capital equipment such as CT scan machine Multi 64 makes to increase the average cost of a patient in centers compared to other health centers. On the other hand, the cost of accidental outpatients is not registered in the system, so these factors make the average cost of hospitals higher than country standard.
Keywords: cost traffic accidents hospital

References

  1. Abu J. Batuwangala, M. & Herbert K. 2005. Retinoic Acid and Retinoid Receptors: Potential Chemopreventive and Therapeutic Role in Cervical Cancer. Lancet Oncol J., 6, 712-720.
  2. Andrijono 2010. Prevention of Post-Mole Malignant Trophoblastic Disease with Vitamin A. Asian Pac J of Cancer Prev, 567-570.
  3. Andrijono, Leli W. 2008. Induction of apoptosis activity bythe administration of retinoic acid on hydatidiform moletrophoblastic cell. 12th Biennial Meeting International Gynecologic Cancer Society - IGCS. Bangkok, Thailand, October 25-28.
  4. Andrijono, et al. 2007. Study on retinolbinding protein (RBP) receptor in hydatidiform moletrophoblastic cells. Med J Indones, 16, 146-50.
  5. Budiana I.N. (2009). Koriokarsinoma Pasca Abortus. J Medicina, 40, 65-72.
  6. Blomhoff R. & Blomhoff H.K. 2006. Overview of retinoid metabolism and function. Journal of Neurobiology. 10: 606-30.
  7. Chiu, P., Feng, H., Benbrook D., Ngan, H., Khoo U., Xue, W., . . . Cheung A. 2006. Effect of all-trans retinoic acid on tissue dynamics of choriocarcinoma cell lines: an organotypic model. J Clin Pathol, 59, 845–8
  8. Guo J.M., Xiao B.X., Kang G.Z., Liu D.H., Chen H., Zhang S. 2006. Suppresion of telomerase activity and arrest at G1 phase in human cervical cancer HeLa cells by all-trans retinoic acid. Int J Gynecol Cancer.16: 341-6.
  9. HIMPUNAN ONKOLOGI GINEKOLOGI INDONESIA. 2011. Pedoman pelayanan medik kanker ginekologi. Jakarta: Himpunan Onkologi Ginekologi Indonesia, 77-85
  10. Lurain J.R. 2010. Gestational trophoblastic disease I: epidemiology, pathology, clinical presentation and diagnosis of gestational trophoblastic disease, and management of hydatidiform mole. Am J of Obst & Gynec, 9(12), 66-87.
  11. Lurain J.R. 2011. Gestational trophoblastic disease II: classification and management of gestational trophoblastic neoplasia. AJOG. 1: 11-8.
  12. Orendi K., Gauster M., Moser G., Mein H., Huppertz B. 2010. The choriocarcinoma cell line BeWo: synctial fusion and expression of synctium-specific proteins. Reproduction. 140:759-66.
  13. Qin X., Zhiyuan Z., Ping Z., Wantao C. 2008. Antisense oligonucleotides and all-trans retinoic acid have a synergistic anti-tumor effect on oral squamous cell carcinoma. BMC Cancer. 8: 1-9.
  14. Santoso, S. 2002. Buku latihan SPSS statistik. Jakarta: Elex Media Computindo.
  15. Shen Z.X., Shi Z.Z., Fang J., Gu B.W., Li J.M., Zhu Y.M. 2004. All-trans retinoic acid/ As2O3 combination yields a high quality remission and survival in newly diagnosed acute promyelocytic leukemia. PNAS. 101: 5328-35.
  16. Strohl A.E., Lurain J.R. 2016. Postmolar choriocarcinoma: An independent risk factor for chemotherapi resistance in low-risk gestational trophoblastic neoplasia. Gynecologic oncology, 141(2):276-80.
  17. Tang X.H., Gudas L.J. 2011. Retinoids, retinoic acid receptors, and cancer. Annual review of pathology. 6:345-64
  18. Taylor F. Shor D, Winter M.C., et al. (2015). A retrospective study to evaluate single agent methotrexate treatment in low risk gestational choriocarcinoma in the United Kingdom. Gynecologic oncology, 136(2):258-63.
  19. US BIOMAX. 2002. Quantitative Telomerase Detection Kit. Catalog No. MT3010, MT3011, MT3012
  21. Xuan, Y.H., KIM, K. H., Choi, Y.-L., Ahn, G., Chae, S. W., Lee, H.-c., & Lee, O.-J. (2008). The Expression of G1-S Cell Cycle Inhibitors in Normal Placenta and Gestational Trophoblastic Diseases. Korean J of Pathol, 42, 67-74.

How to Cite

Mahdiyan, S. M., Asgari, K. A., & Ranjbar, M. (2018). Cost for traffic accident related injuries and its comparison it with the national standard: A case study in Iran. Bali Medical Journal, 7(2), 511–515. https://doi.org/10.15562/bmj.v7i2.616
ACM ACS APA ABNT Chicago Harvard IEEE MLA Turabian Vancouver
Download Citation
Endnote/Zotero/Mendeley (RIS) BibTeX

HTML
3

Total
1

Share

Search Panel

Somayeh Mahdiyan Mahdiyan
Google Scholar
Pubmed
BMJ Journal

Kavos Asgari Asgari
Google Scholar
Pubmed
BMJ Journal

Mohammad Ranjbar
Google Scholar
Pubmed
BMJ Journal